Hartmut Goldschmidt
0000-0003-0961-0035
Publication & Citation Trends
Publications
1,422 total
Prognostic Impact of the Hevylite Assay in Patients With IgG or IgA Multiple Myeloma Treated Within the GMMG‐MM5 Trial
Cited by 0
Semantic Scholar
Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma—Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income Countries OA
Cited by 1
Semantic Scholar
Bortezomib before and after high‐dose therapy in transplant‐eligible patients with newly diagnosed multiple myeloma: Long‐term overall survival after more than 10 years of follow‐up from the phase III HOVON‐65/GMMG‐HD4 trial OA
Cited by 2
Semantic Scholar
Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation
Cited by 1
Semantic Scholar
Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial OA
Cited by 0
Semantic Scholar
Efficacy and Safety of Autologous Stem Cell Transplantation in First-Line Treatment and at Relapse in Elderly Patients with Multiple Myeloma
Cited by 1
Semantic Scholar
EASIX-guided risk stratification for complications and outcome after CAR T-cell therapy with ide-cel in relapsed/refractory multiple myeloma OA
Cited by 29
Semantic Scholar
Research Topics
Multiple Myeloma Research and Treatments
(1128)
Protein Degradation and Inhibitors
(433)
Cancer Treatment and Pharmacology
(242)
Peptidase Inhibition and Analysis
(179)
Amyloidosis: Diagnosis, Treatment, Outcomes
(94)
Affiliations
Università Cattolica del Sacro Cuore
Brigham and Women's Hospital
Novartis (Switzerland)
City Of Hope National Medical Center
Deaconess Hospital